Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
BCAS3
REST API REST API
Homo sapiens
BCAS3 is differentially expressed in 180 experiments: 61 organism parts: ovary, blood, ... (59 more);, 65 disease states: normal, glioblastoma, ... (63 more);, 59 cell types 213 cell lines 27 compound treatments and 57 other conditions.
Synonyms FLJ20128
Orthologs bcas3 (Danio rerio)   Bcas3 (Mus musculus)   BCAS3 (Gallus gallus)   BCAS3 (Bos taurus)   ENSCING00000013413 (Ciona intestinalis)   Bcas3 (Rattus norvegicus)   ENSCING00000008679 (Ciona intestinalis)   bcas3 (Xenopus laevis)   ENSCAFG00000024122 (Canis familiaris)   ENSCAFG00000017748 (Canis familiaris)   CG43154 (Drosophila melanogaster)   (Compare orthologs)
Gene Ontology Term cytoplasm, nucleus, cell periphery
UniProt Accession Q9H6U6, Q70WD9
InterPro Term BCAS3, WD40_repeat_subgr
Search EB-eye ENSG00000141376
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-MEXP-1251, E-MTAB-24, E-MTAB-25, ... (17 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-MTAB-62, ... (25 experiments)

Factor Value U/D Experiments
BT474
3
E-MTAB-37, E-MEXP-440, E-MTAB-62
MCF-7
3
E-GEOD-19639, E-GEOD-3529, E-GEOD-20081
MDA468
2
E-MEXP-440, E-MTAB-62
A549
2
E-GEOD-3202, E-GEOD-6013
MCF7
2
E-GEOD-5258, E-MTAB-37
PC3
2
E-GEOD-5258, E-MEXP-2034
207 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-21668, E-MEXP-750, E-GEOD-20677, E-GEOD-13987, ... (32 experiments)

Factor Value U/D Experiments
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
adipose stem cells derived from adult human donor
1
E-GEOD-20033
bronchial epithelial
1
E-MTAB-25
macrophage
1
E-GEOD-5099
hMOF over-expressed
1
E-GEOD-20193
M2 macrophage
1
E-GEOD-5099
53 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-GEOD-16363, E-GEOD-9692, ... (32 experiments)

Factor Value U/D Experiments
glioblastoma
2
E-GEOD-4290, E-GEOD-6014
lung carcinoma
2
E-MTAB-37, E-GEOD-6014
myeloma
1
E-MTAB-37
DiseaseState
1
E-MEXP-1243
lung adenocarcinoma
1
E-MEXP-231
septic shock
1
E-GEOD-9692
59 more value(s).


Compound treatment

studied in E-GEOD-4668, E-TABM-782, E-GEOD-3720, E-GEOD-7708, E-TABM-868, ... (20 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-TABM-868, E-GEOD-3720
none
3
4
E-TABM-868, E-GEOD-7307, E-GEOD-5099, E-MEXP-1601, E-GEOD-4668, ... (7 experiments)
resveratrol
1
E-TABM-782
interleukin-22 (Homo sapiens)
1
E-GEOD-7216
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
glutamine
1
E-MEXP-1335
21 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-7967, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-MEXP-2359, E-GEOD-2666, E-GEOD-4667, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-21138

Environmental stress
studied in E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-17385, E-MEXP-563

Genotype
studied in E-TABM-1029, E-GEOD-3494, E-GEOD-17476, E-TABM-868, E-TABM-601, ... (6 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-MEXP-2657, E-MEXP-1103, E-MEXP-2146 ... (5 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1432, E-GEOD-19330, E-TABM-666, ... (19 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12108, E-GEOD-17400

Injury
studied in E-GEOD-19743, E-GEOD-5372

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-MEXP-958

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-21750

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19246, E-GEOD-1343

RNAi
studied in E-MEXP-2115, E-GEOD-12438, E-MEXP-1509, E-GEOD-3697, E-MEXP-1857, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sample status
studied in E-GEOD-30573

sampleID
studied in E-GEOD-24283

Sex
studied in E-GEOD-22541

Stimulation
studied in E-GEOD-4883, E-GEOD-11428

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-33562, E-MEXP-973, E-GEOD-19815

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561

Tumor size
studied in E-GEOD-6532

Vehicle
studied in E-GEOD-5258

Processing time: 0.469 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM